Markets
Data Center
(Nathan Howard/Getty Images)

The nuclear-powered AI data-center trade roars into a new year

It’s early going, but so far the trade of the year is clearly another big bet on an ongoing boom in an AI-related investment.

Just check out the top gainers of the S&P 500 in the first two days of 2025 trading.

Nuke stocks Vistra and Constellation Energy — the second- and 10th-best peformers in the index last year — exploded out of the gates amid rising expectations of growing demand from power-hungry data centers.

Giant landowner Texas Pacific Land, which traditionally leased its massive holdings of West Texas land for oil and gas drilling but has recently talked up the potential for slapping up data centers, comes next.

Then embattled server-hardware maker Super Micro Computer, another nuke stock NRG, the Magnificient 7’s Nvidia, renewables and power-generation firm GE Vernova, disk-drive maker Western Digital, a newly enlivened Uber, and finally Micron. We could go on, with the next tier of top performers including more tech, AI, and energy-related firms like First Solar, Enphase Energy, and Palantir.

For what it’s worth, there are plenty of reasons to believe that this bet on the continued boom in AI investment is pretty much a sure thing.

For instance, Friday Microsoft said it was going to spend $80 billion to build AI data centers in fiscal 2025 alone. That can buy a lot of chips.

But from a slightly longer-term perspective, nervous Nellies can’t help but wonder whether such a single-minded investment mania might be setting up the US economy — and potentially the markets — for the mother of all malinvestment cycles, akin to or perhaps worse than the tech-stock boom of the late 1990s that turned into a gnarly stock-market bust by 2001. But that’s all ancient history.

This time is, of course, completely different.

More Markets

See all Markets
markets

Spectrum owner Charter Communications is on pace for its worst day ever as broadband numbers and Q1 results disappoint

Cable and broadband company Charter Communications is on pace for its worst-ever trading day on Friday, as investors dump the stock following its Q1 results and forward guidance.

Charter, which owns Spectrum, reported adjusted earnings of $9.17 per share, below Wall Street estimates of $9.96 per share from analysts polled by FactSet. On the company’s earnings call, CFO Jessica Fischer appeared to lower its guidance for full-year revenue per user.

“It’ll be close either way in terms of whether we end up with net growth,” Fischer said.

The company lost 120,000 internet subscribers in the quarter, deeper than the expected 94,800 and double its loss from the same period last year. That news comes one day after Comcast’s earnings provided a bit of optimism for broadband as a category: the company reported Q1 losses of 65,000, significantly improving from 183,000 losses in the same quarter last year. Comcast is down more than 10%, on pace for its worst day since January 2025.

markets

Nvidia poised to snap longest run without a record close since the AI boom began

The stock price of the company responsible for the brains of the AI boom is finally showing some brawn again.

Nvidia, the world’s most valuable company, is poised to close at a record high for the first time since October 29, 2025, on Friday (if it ends above $207.04).

The AI chip trade is on fire, with the Philadelphia Semiconductor Index slated to deliver its 18th consecutive gain as Intel’s robust results and outlook juice the entire ecosystem. Hyperscalers report earnings next week, and their capex guidance can be thought of as the earnings guidance for Nvidia and other AI suppliers for the quarters to come.

This would end Nvidia’s longest stretch without a record close since the unofficial start of the AI boom (when the chip designer delivered blowout quarterly results in May 2023).

(Sorry if I jinx this!)

markets

Lilly slips after prescriptions for its weight-loss pill come in below expectations in second week

Eli Lilly fell on Friday after prescription data for its new weight-loss pill, Foundayo, showed that it’s having a significantly slower rollout than its top competitor.

The pill was prescribed about 3,700 times in its second week, according to IQVIA data cited by Deutsche Bank analysts, compared to the roughly 8,000 they were expecting. Novo Nordisk’s Wegovy pill, which came out in January, hit over 18,000 prescriptions in its second week.

The FDA approved Foundayo on April 1 and shipments began on April 9. Deutsche analysts noted that Lilly’s GLP-1 injections, which currently outsell Novo’s, also had a slower start.

Lilly fell more than 4% after the numbers were released. Novo Nordisk rose more than 5%.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.